Status:
UNKNOWN
Prevelance Of Cutaneous Disorders Among Patients With Heamatologic Malignancies
Lead Sponsor:
Sohag University
Conditions:
Dermatologic Disorders With Heamatologic Malignancies Patients
Eligibility:
All Genders
Brief Summary
Hematologic malignancies are a diverse group of neoplasms that can have a wide range of clinical and behavioral characteristics. Infections are also a common complication of hematologic malignancies, ...
Detailed Description
hematologic malignancies are a diverse group of neoplasms that can have a wide range of clinical and behavioral characteristics. The skin is often involved in these diseases, either through direct inf...
Eligibility Criteria
Inclusion
- Age: all age groups.
- Sex: both sex will be included.
- Patients with confirmed diagnosis of haematological malignancies ethier clinically or laboratory.
Exclusion
- Pregnancy., • Patients with medical comorbidities (liver ,renal ,thyroid abnormalities ,other malignancies)
Key Trial Info
Start Date :
November 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
November 1 2024
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT06108622
Start Date
November 1 2023
End Date
November 1 2024
Last Update
October 31 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sohag university Hospital
Sohag, Egypt, Sohag